IRIS
TROVATO, Maria Concetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.460
NA - Nord America 4.155
AS - Asia 2.185
SA - Sud America 784
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 68
OC - Oceania 6
Totale 11.772
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.092
RU - Federazione Russa 2.109
SG - Singapore 956
BR - Brasile 678
CN - Cina 662
IE - Irlanda 533
SE - Svezia 524
FR - Francia 292
UA - Ucraina 253
HK - Hong Kong 246
DE - Germania 236
IT - Italia 218
FI - Finlandia 119
VN - Vietnam 100
GB - Regno Unito 89
AR - Argentina 45
IN - India 43
BD - Bangladesh 25
CA - Canada 23
TR - Turchia 22
MA - Marocco 20
BE - Belgio 18
MX - Messico 17
IQ - Iraq 16
NL - Olanda 14
ZA - Sudafrica 14
CO - Colombia 12
EC - Ecuador 12
ID - Indonesia 11
JP - Giappone 11
VE - Venezuela 11
UZ - Uzbekistan 10
ES - Italia 8
PK - Pakistan 8
AZ - Azerbaigian 7
CL - Cile 7
CR - Costa Rica 7
CZ - Repubblica Ceca 7
EG - Egitto 7
SA - Arabia Saudita 7
AL - Albania 6
IR - Iran 6
JO - Giordania 6
UY - Uruguay 6
IL - Israele 5
KE - Kenya 5
PY - Paraguay 5
RO - Romania 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CI - Costa d'Avorio 4
DK - Danimarca 4
DZ - Algeria 4
EU - Europa 4
KR - Corea 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
OM - Oman 4
PE - Perù 4
PH - Filippine 4
TN - Tunisia 4
BO - Bolivia 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
NP - Nepal 3
PS - Palestinian Territory 3
SN - Senegal 3
AU - Australia 2
BB - Barbados 2
BG - Bulgaria 2
CH - Svizzera 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
KG - Kirghizistan 2
KH - Cambogia 2
LV - Lettonia 2
MM - Myanmar 2
MN - Mongolia 2
MY - Malesia 2
PA - Panama 2
PL - Polonia 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
NG - Nigeria 1
NI - Nicaragua 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 11.658
Salva come PNG Salva come JPEG
Città #
Moscow 620
Dublin 532
Ashburn 531
Singapore 514
Jacksonville 496
Chandler 351
Dallas 267
Beijing 258
Hong Kong 245
Nyköping 243
Council Bluffs 188
San Jose 188
The Dalles 108
Princeton 100
Cambridge 98
Lauterbourg 95
Ann Arbor 86
Medford 85
Los Angeles 78
Des Moines 69
Dearborn 60
Messina 50
Boardman 44
Buffalo 44
Munich 37
São Paulo 36
Wilmington 35
Ho Chi Minh City 34
Woodbridge 31
New York 30
Bremen 29
Redondo Beach 29
Jinan 27
Santa Clara 27
Nanjing 23
San Mateo 23
Guangzhou 22
Rio de Janeiro 22
Belo Horizonte 21
Tianjin 21
Columbus 20
Hanoi 19
Houston 19
Mazzarra Sant'andrea 19
Brussels 18
Seattle 17
Lancaster 16
Shenyang 16
Turku 16
Brasília 14
Chicago 14
Falls Church 14
Orem 13
Hangzhou 12
Miami 12
Taizhou 12
Atlanta 10
London 10
Phoenix 10
Rome 10
Shanghai 10
Tokyo 10
Zhengzhou 10
Brooklyn 9
Chennai 9
Curitiba 9
Haikou 9
Helsinki 9
Ribeirão Preto 9
Baghdad 8
Frankfurt am Main 8
Hillsboro 8
João Pessoa 8
San Francisco 8
Sorocaba 8
Tashkent 8
Acireale 7
Clearwater 7
Fuzhou 7
Gravataí 7
Hebei 7
Ningbo 7
Amsterdam 6
Auburn Hills 6
Baku 6
Bogotá 6
Changsha 6
Denver 6
Haiphong 6
Nova Iguaçu 6
Piracicaba 6
Porto Alegre 6
Salvador 6
São José dos Campos 6
Washington 6
Betim 5
Buenos Aires 5
Cairo 5
Campinas 5
Carapicuíba 5
Totale 6.373
Salva come PNG Salva come JPEG
Nome #
Expression of P53 and isoforms in bening and malignant lesions of the head and neck 217
Immunoreactions for P53 isoforms are associated with ultrastructural proliferative profiles in benign thyroid nodules 201
Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions 200
Allelic loss at 7q21 is a frequent and early event in thyroid follicular tumors. 193
CD30 and CD30 ligand (CD30L) expression in decidual samples of spontaneous abortions. 188
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor 187
Analisi immunoistochimica dei "pathways" del sistema HGF/c-met in noduli tiroidei benigni e maligni. 184
Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules 178
Realtà complesse ed epidemiologia di un fenomeno 175
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 173
Expression of NA/1 symporter (NIS) in endometrial mucosa of fertile, sterile and post-menopausal women. 172
Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by hashimoto's thyroiditis 171
Comparative analysis of diagnostic performance, feasibility and cost of different test-methods for thyroid nodules with indeterminate cytology 164
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 163
Cell-specific loss of heterozygosity (LOH) on chromosome 7q21 in thyroid tumors: analysis on 267 laser capture microdissected thyroid lesions 159
APLOTIPI DEL MICROSATELLITE D7S6440 INTERNO AL GENE HIPK2 COME MARCATORI DELLA TIROIDE AUTOIMMUNITARIA 159
Expression of CD30 ligand and CD30 receptor in normal thyroid and benign and malignant thyroid nodules 158
Cellule giganti tipo corpo estraneo nel carcinoma papillare della tiroide 157
Expressions of Δ 133 isoforms of P53 in multinodular thyroids: the immunoreactions in benign lesions are correlating with subcellular phenotypes of electron microscopy 157
Deposito presso la GenBank della sequenza genica del microsatellite di 360 bp denominato “D7S6440”, trovato nell’Homo sapiens, localizzato nel cromosoma 7q 32-34, all’interno del gene HIPK2, a livello dell’introne 9; con tandem di ripetizione fra 173..198 bp costituito da sequenze “ca”. 154
Cancer Thyroid Nodule: Knowing is Doing 151
Hepatocyte growth factor/C-met axis in thyroid cancer: From diagnostic biomarker to therapeutic target 151
Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas 148
HGF/C-MET system pathways in benign and malignant histotypes of thyroid nodules: an immunohistochemical characterization 147
CD£0 ligand (CD30L)/CD30 receptor (CD30) signaling in benign and malignant thyroid nodules 146
Compared with healthy controls, serum hepatocyte growth factor (HGF) is increased in the nodular variant of Hashimoto's thyroiditis (HT) more than in the nonnodular variant, whereas serum interleukin-6 (IL-6) is increased regardless of associated thyroid nodules. 144
Cell-type specifc loss of heterozygosity (LOH) on chromosome 7q21 in thyroid tumors: analysis on 267 laser capture microdissected thyroid lesions 143
Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals 142
Thyroid hemiagenesis, Graves' disease and differentiated thyroid cancer: a very rare association: case report and review of literature 140
The new era of vaccines: the “nanovaccinology” 138
Ultrastructural findings of thyrocytes are signatures for an accurate interpretation of cytological aspirates 138
Differential expression of the HGF/c-met ligand/receptor signaling and three downstream molecules (STAT3, PI3K, RHO) in benign and malignant thyroid nodules. 137
Combined clinical and ultrasound follow-up assists in malignancy detection in Galectin-3 negative Thy-3 thyroid nodules 137
Compendio di Anatomia Patologica 133
Differential expression of the HGF/c-met ligand/receptor signaling and three downstream molecules (STAT3, PI3K, RHO) in benign and malignant thyroid nodules: possible implications for pharmachologic treatment of the differentiated thyroid cancer (DTC). 131
EGF, TGF-alpha, EGF receptor (EGFR) and somatostatin receptors 2 (SSR2) in acanthosis nigricans (AN) 124
The tyrosine kinase receptor c-met, its cognate ligand HGF and the tyrosine kinase receptor trasducers STAT3, PI3K and RHO in thyroid nodules associated with Hashimoto's thyroiditis: an immunohistochemical characterization. 123
Multidrug resistance protein 2 (MRP2) nei carcinomi midollari della tiroide 120
Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer 117
TP53 polymorphism may contribute to genetic susceptibility to develop Hashimoto's thyroiditis 117
Espressione di CD30 e CD30 ligando nelle decidue di aborti spontanei 116
STAT3 is selectively expressed in papillary thyroid cancer (PTC) and some follicular adenomas 115
Serum interleukin-6 levels are increased in HIV-infected patients that develop autoimmune disease during long-term follow-up 115
Multidrug-resistance protein 2 (MRP-2) expression in medullary thyroid carcinoma. 114
What is New on Thyroid Cancer Biomarkers 114
Immunoexpression of CD30 and CD30 ligand in deciduas from spontaneous abortions 114
LACK OF SOMATOSTATIN ANALOGS (SSAS) EFFECTIVENESS IN GONADOTROPIN-SECRETING PITUITARY ADENOMAS: REPORT OF A CASE AND A REVIEW OF THE LITERATURE 111
Immunoexpression of the hepatocyte growth factor (HGF), HGF- receptor (c-met) and STAT3 on placental tissues from malformed fetuses 110
Espressione del CDX2 nelle varie fasi dello sviluppo placentare 107
Nanostructures: between natural environment and medical practice. 104
Perdita di eterozigosi su 7q21 nella patologia multinodulare della tiroide 103
Expression of hepatocyte growth factor in Hashimoto's thyroiditis with nodular lesions 102
Repression of the Antiapoptotic Molecule Galectin-3 by Homeodomain-Interacting Protein Kinase 2-Activated p53 Is Required for p53-Induced Apoptosis. 102
Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness. 101
New Research Communication on Thyroid Tumor Markers 101
METODO PER LA DIAGNOSI IN VITRO DI CARCINOMA TIROIDEO 101
Infezione occulta da virus dell’epatite B in pazienti con epatite cronica virus con correlata valutazione istologica 99
L'espressione di STAT3 èpiù frequentemente associata al sistema HGF7c-met rispetto ad IL-6/IL6R nei carcinomi papillari e negli adenomi follicolari tiroidei 98
Multidrug resistance protein-2 (MRP-2) nel carcinoma midollare della tiroide. 98
Loss of heterozygosity for 7q21.1 and 31.3 is peculiar of follicular and anaplastic, but not papillary, thyroid cancers 98
The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas 98
EGF, TGFA-apla, EGF receptor (EGFR) and somatostatin receptors (SSR2) in acanthosis nigricans (AN) 97
Espressione immunoistochimica di HGF, c-met e STAT3 in placente da gravidanze con feti malformati 97
Expression of transcription factor STAT3 associated to HGF/c-met system in normal and pathological thyroid tissue. 96
Immunoexpression of multidrug-resistance protein 2 and cyclooxygenase 2 in medullary thyroid carcinomas 95
Distinctive expression of STAT3 in papillary thyroid carcinoma and a subset of follicular adenomas. 94
Immunoexpression of the CD30 ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases 92
La perdita di eterozigosità (LOH) per markers sul braccio lungo del cromosoma 7 (7q) è peculiare dei carcinomi tiroidei follicolari (FTC) e anaplastici (ATC), non dei papillari (PTC). 91
LOH sul braccio lungo del cromosoma 7 è una frequente alterazione genetica nel carcinoma follicolare ed anaplastico della tiroide. 91
SELECTIVE RADIO-GUIDED NECK DISSECTION FOR CERVICAL LYMPH NODE METASTASIS FROM OCCULT THYROID CANCER: REPORT OF A CASE 91
Prognostic and predictive biomarkers in thyroid diseases: “magic bullets” for a personalized therapeutic strategy 91
Immunodimostrazione dell'antigene K-1 (CD30) nella patologia autoimmune e neoplastica della tiroide. 90
Expression of transcription factor STAY3 associated to HGF/c-met and IL-6/IL-6r sistems in normal and pathologic thyroid tissue 89
Espressione dei fattori della morfogenesi negli organi e nelle placente di feti a varie epoche di gestazione 89
Hepatocyte growth factor (HGF) expression and circulating levels in nodular Hashimoto's thyroiditis. 89
MULTIDRUG-RESISTANCE PROTEIN 2 (MRP2) E CICLO-OSSIGENASI 2 (COX2) NEL CARCINOMA MIDOLLARE DELLA TIROIDE. 88
New Research Communication on Thyroid Tumor Markers 88
Interleukin‑6 signalling as a valuable cornerstone for molecular medicine 88
Espressione genica della via p53/HGF/c-met /STAT3 nei feti con malformazioni del sistema nervoso. 87
Loss of heterozygosity of 7q21.1 and 7q31.3 is peculiar of follicular and anaplastic, but not papillary, thyroid cancer. 86
Expression of IL6/IL6R and CD30L/C30 in normal thyroid and thyroid nodules. 86
THE LOSS OF THE P53 ACTIVATOR HIPK2 IS RESPONSIBLE FOR GALECTIN-3 OVEREXPRESSIONIN WELL DIFFERENTIATED THYROID CARCINOMAS 86
Hepatocyte growth factor (HGF) expression in nodular Hashimoto thyroditis. 84
The use of Laser Capture Microdissection in the identification of new putative oncosoppressor genes in thyroid cancer. 82
Espressione dlel'hepatocyte growth factor (HGF) e del suo recettore (HGF-R o c-met) nei carcinomi papillari tiroidei. 80
Serum Amyloid A (SAA) expression by medullary thyroid cancer (MTC). 80
EXPRESSION IN DECIDUAL SAMPLES OF SPONTANEOUS ABORTIONS. 80
Polimorfismo dle gene TP53 nrlla tiroidite di Hashimoto (TH). 80
Serum Levels And Immohistochemical Expression Of Hepatocyte Growth Factor (Hgf) in Hashimoto Thyroiditis 79
Serum levels and immunochemical expression of hepatocyte growth factor (HGF) in Hashimoto's thyroiditis. 79
Serum levels and immunohistochemical expression of Hepatocyte Growth Factor (HGF) in Hashimoto thyroiditis. 78
Immunohistochemical expression of HGF, c-met and transcription-factor STAT3 in colorectal tumors. 77
Single Nucleotide Polymorphisms (SNPs) in exon 4 of p53 as genetic markers of susceptibility for Hashimoto’s thyroiditis (HT) 75
Serum amyloid A (SAA) expression in medullary thyroid cancer (MTC). 73
Dimostrazione immunocitochimica dell'Hepatocyte Growth Factor (HGF) e del suo recettore c-met nel tessuto tiroideo normale e patologico. 73
Expression of HGF and HGF-receptor (c-met) in the papillary thyroid cancer (PTC). 73
Expression of p53/ HGF/c-met/ STAT3 signal in fetus with malformation of nervous system. 70
Expression of p53/hgf/c-met/STAT3 signal in fetuses with neural tube defects 69
Papillary and follicular thyroid carcinomas show LOH in two distinct regions of the long arm of chromosome 7 69
Specific haplotypes of a microsatellite markers internal to the HIPK2 gene in Hashimoto thyroditis 67
Totale 11.727
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.885
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.885
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022571 0 0 0 34 31 7 44 32 14 110 103 196
2022/20231.524 123 107 64 102 123 171 16 94 653 3 55 13
2023/2024332 31 60 31 46 39 48 4 34 0 7 2 30
2024/20251.732 15 32 35 115 73 80 16 421 441 80 107 317
2025/20264.689 222 311 278 295 430 1.117 570 553 592 170 65 86
2026/2027638 80 188 193 177 0 0 0 0 0 0 0 0
Totale 11.772